Drugs.com Clinical Trial ResultsOriginal article
Capricor Therapeutics Provides Update on FDA Advisory Committee Meeting for Deramiocel
AdComDeramiocelNeutral
AI Analysis
Summary
Capricor Therapeutics announced an FDA Advisory Committee Meeting update regarding Deramiocel. The company is developing cell and exosome-based therapeutics for rare diseases.
Importance:7/10
Sentiment:
0.00
FDA Advisory CommitteeCell TherapyExosome-based TherapeuticsRare Diseases
Related Companies
Read the original article
Published by Drugs.com Clinical Trial Results on July 30, 2026 2:07 AM